BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 18841201)

  • 1. Identification of nuclear and cytoplasmic mRNA targets for the shuttling protein SF2/ASF.
    Sanford JR; Coutinho P; Hackett JA; Wang X; Ranahan W; Caceres JF
    PLoS One; 2008 Oct; 3(10):e3369. PubMed ID: 18841201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversible phosphorylation differentially affects nuclear and cytoplasmic functions of splicing factor 2/alternative splicing factor.
    Sanford JR; Ellis JD; Cazalla D; Cáceres JF
    Proc Natl Acad Sci U S A; 2005 Oct; 102(42):15042-7. PubMed ID: 16210245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel role for shuttling SR proteins in mRNA translation.
    Sanford JR; Gray NK; Beckmann K; Cáceres JF
    Genes Dev; 2004 Apr; 18(7):755-68. PubMed ID: 15082528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alternative splicing factor or splicing factor-2 plays a key role in intron retention of the endoglin gene during endothelial senescence.
    Blanco FJ; Bernabeu C
    Aging Cell; 2011 Oct; 10(5):896-907. PubMed ID: 21668763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding sites for Rev and ASF/SF2 map to a 55-nucleotide purine-rich exonic element in equine infectious anemia virus RNA.
    Chung H ; Derse D
    J Biol Chem; 2001 Jun; 276(22):18960-7. PubMed ID: 11278454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stability of a PKCI-1-related mRNA is controlled by the splicing factor ASF/SF2: a novel function for SR proteins.
    Lemaire R; Prasad J; Kashima T; Gustafson J; Manley JL; Lafyatis R
    Genes Dev; 2002 Mar; 16(5):594-607. PubMed ID: 11877379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic analysis of the SR protein ASF/SF2: interchangeability of RS domains and negative control of splicing.
    Wang J; Xiao SH; Manley JL
    Genes Dev; 1998 Jul; 12(14):2222-33. PubMed ID: 9679066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of the SR proteins 9G8, SC35, ASF/SF2, and SRp40 on the utilization of the A1 to A5 splicing sites of HIV-1 RNA.
    Ropers D; Ayadi L; Gattoni R; Jacquenet S; Damier L; Branlant C; Stévenin J
    J Biol Chem; 2004 Jul; 279(29):29963-73. PubMed ID: 15123677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SF2/ASF regulates proteomic diversity by affecting the balance between translation initiation mechanisms.
    Blaustein M; Quadrana L; Risso G; Mata Mde L; Pelisch F; Srebrow A
    J Cell Biochem; 2009 Jul; 107(4):826-33. PubMed ID: 19441081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel exploitation of a nuclear function by influenza virus: the cellular SF2/ASF splicing factor controls the amount of the essential viral M2 ion channel protein in infected cells.
    Shih SR; Krug RM
    EMBO J; 1996 Oct; 15(19):5415-27. PubMed ID: 8895585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human splicing factor ASF/SF2 encodes for a repressor domain required for its inhibitory activity on pre-mRNA splicing.
    Dauksaite V; Akusjärvi G
    J Biol Chem; 2002 Apr; 277(15):12579-86. PubMed ID: 11801589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. hnRNP A1 and the SR proteins ASF/SF2 and SC35 have antagonistic functions in splicing of beta-tropomyosin exon 6B.
    Expert-Bezançon A; Sureau A; Durosay P; Salesse R; Groeneveld H; Lecaer JP; Marie J
    J Biol Chem; 2004 Sep; 279(37):38249-59. PubMed ID: 15208309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mapping the SF2/ASF binding sites in the bovine growth hormone exonic splicing enhancer.
    Dirksen WP; Li X; Mayeda A; Krainer AR; Rottman FM
    J Biol Chem; 2000 Sep; 275(37):29170-7. PubMed ID: 10880506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The splicing factor SF2/ASF regulates translation initiation by enhancing phosphorylation of 4E-BP1.
    Michlewski G; Sanford JR; Cáceres JF
    Mol Cell; 2008 Apr; 30(2):179-89. PubMed ID: 18439897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The human splicing factors ASF/SF2 and SC35 possess distinct, functionally significant RNA binding specificities.
    Tacke R; Manley JL
    EMBO J; 1995 Jul; 14(14):3540-51. PubMed ID: 7543047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SF2/ASF autoregulation involves multiple layers of post-transcriptional and translational control.
    Sun S; Zhang Z; Sinha R; Karni R; Krainer AR
    Nat Struct Mol Biol; 2010 Mar; 17(3):306-12. PubMed ID: 20139984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arginine methylation controls the subcellular localization and functions of the oncoprotein splicing factor SF2/ASF.
    Sinha R; Allemand E; Zhang Z; Karni R; Myers MP; Krainer AR
    Mol Cell Biol; 2010 Jun; 30(11):2762-74. PubMed ID: 20308322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The CD44 alternative v9 exon contains a splicing enhancer responsive to the SR proteins 9G8, ASF/SF2, and SRp20.
    Galiana-Arnoux D; Lejeune F; Gesnel MC; Stevenin J; Breathnach R; Del Gatto-Konczak F
    J Biol Chem; 2003 Aug; 278(35):32943-53. PubMed ID: 12826680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The splicing factor-associated protein, p32, regulates RNA splicing by inhibiting ASF/SF2 RNA binding and phosphorylation.
    Petersen-Mahrt SK; Estmer C; Ohrmalm C; Matthews DA; Russell WC; Akusjärvi G
    EMBO J; 1999 Feb; 18(4):1014-24. PubMed ID: 10022843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HnRNP A1/A2 and SF2/ASF regulate alternative splicing of interferon regulatory factor-3 and affect immunomodulatory functions in human non-small cell lung cancer cells.
    Guo R; Li Y; Ning J; Sun D; Lin L; Liu X
    PLoS One; 2013; 8(4):e62729. PubMed ID: 23658645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.